Besides altered glycosylation, galectin-3 expression is commonly dysregulated within the tumor microenvironment, either by altered expression in tumor cells or by its expression in infiltrating leukocytes [for a comprehensive list of studies in human tumors, see Ref. The gene discussed is LGALS3; the disease is neoplasm.